Background and Objectives: Of 200 volunteer blood donors we had screened earlier for hepatitis E virus (HEV) RNA, using reverse–transcription polymerase chain reaction, 3 were positive, raising the possibility of transfusion–associated hepatitis E in areas endemic for this virus. This retrospective study was to reassess the extent of post–transfusion hepatitis E among transfusion recipients, investigated in 1982. Materials and Methods: We re–evaluated 56 recipients followed biweekly for 3 months after transfusion. The controls were 51 normal, healthy persons who gave blood at a 2–month interval, as well as 412 blood donors from whom blood was taken once in 1982. Results: Of the 56 transfusion recipients, 19 were positive for IgG antibodies against HEV (anti–HEV) in the pretransfusion sample. Two of the 37 IgG anti–HEV–negative recipients seroconverted to IgM and IgG anti–HEV 5 and 4 weeks after transfusion, 1 with raised serum alanine aminotransferase levels. None showed symptoms of hepatitis. Attempts to detect HEV RNA in transfused blood, from aliquot units stored at –20°C for over 17 years, were not successful. Of the controls, 17 out of 51 were IgG anti–HEV positive in the initial sample itself. None of the 34 IgG anti–HEV–negative controls seroconverted during the 2–month follow–up. Of the blood donors, 154 out of 412 were IgG anti–HEV positive. None of the 412 donors had circulating IgM anti–HEV antibodies. A significantly higher (p<0.03) proportion of susceptible transfusion recipients were IgM anti–HEV positive as compared with susceptible blood donors. Conclusion: The results suggest that, in countries where HEV is endemic, the transmission of hepatitis E may be associated with blood transfusion.

1.
Arankalle VA, Chadha MS, Tsarev SA, Emerson SU, Risbud AR, Banerjee K, Purcell RH: Seroepidemiology of water–borne hepatitis in India and evidence for a third enterically transmitted agent. Proc Natl Acad Sci USA 1994; 91:3428–3432.
2.
Arankalle VA, Chobe LP, Jha J, Chadha MS, Banerjee K, Favorov MO, Kalinina T, Fields H: Aetiology of acute sporadic non–A, non–B viral hepatitis in India. J Med Virol 1993;40: 121–125.
3.
Arankalle VA, Chobe LP: Hepatitis E virus: Can it be transmitted parenterally? J Viral Hepat 1999;5:199–202.
4.
Tsarev SA, Tsareva TS, Emerson SU, Kapikian AZ, Ticehurst J, London W, Purcell RH: ELISA for antibody to hepatitis E virus (HEV) based on complete open–reading frame–2 protein expressed in insect cells: Identification of HEV infection in primates. J Infect Dis 1993;168:369–378.
5.
Arankalle VA, Tsarev SA, Chadha MS, Alling DW, Emerson SU, Banerjee K, Purcell RH: Age–specific prevalence of antibodies to hepatitis A and E viruses in Pune, India, 1982 and 1992. J Infect Dis 1995;171:447–450.
6.
Chobe LP, Chadha MS, Banerjee K, Arankalle VA: Detection of HEV RNA in faeces, by RT–PCR during the epidemics of hepatitis E in India (1976–1995). J Viral Hepat 1997;4:129– 133.
7.
Wang J–T, Lin J–T, Sheu J–C, Wang T–H, Chen D–S: Hepatitis E virus and posttransfusion hepatitis. J Infect Dis 1994;169:229–230.
8.
Dasarathy S, Misra SC, Acharya SK, Irshad M, Joshi YK, Venugopal P, Tandon BN: Prospective controlled study of post–transfusion hepatitis after cardiac surgery in a large referral hospital in India. Liver 1992;12:116–120.
9.
Irshad M, Acharya SK, Joshi YK: Prevalence of hepatitis C virus antibodies in the general population and in selected groups of patients in Delhi. Indian J Med Res 1995;102:162–164.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.